USPTO serial 79264098
CORDENPHARMA
Reviewed by CopyMark Law Group
Reg. 6055635Status 404
- Filing date
- Status date
- Registration date
- May 19, 2020
- Examiner
- BELENKER, ESTHER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CORDENPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LU
LU
LU
Corden Pharma International GmbH
DE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom manufacture of pharmaceutical products; treatment of chemical products; recycling of chemical products | SECTION 70 - CANCELLED | — |
| 042 | Pharmaceutical research services; quality evaluation of pharmaceutical products; development of pharmaceutical products; inspection of pharmaceutical products; research in the field of pharmaceutical products; testing on pharmaceutical products; pharmaceutical product development services; development of pharmaceutical preparations and medicines; laboratory research services concerning pharmaceutical products; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; provision of information concerning the results of clinical trials for pharmaceutical products; industrial packaging design services; chemical laboratory services; chemical engineering services; chemical analysis; chemical research; testing of chemical products; chemical technology research; analysis of the chemical composition of liquids; evaluation of chemical information to estimate risk levels | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Corden Pharma Holding S.E.
- Other trademarks owned by Corden Pharma Holding S.E.
- Other trademarks owned by Corden Pharma Holding S.E.
- Other trademarks owned by Corden Pharma International GmbH
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named CORDENPHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 9, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 19, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 19, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 28, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Oct 11, 2020 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 23, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 22, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 19, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 19, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 3, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 3, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 12, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 12, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 12, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 19, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 28, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 28, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 4, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 3, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 7, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |